Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Tivic Health Systems (TIVC) Operating Expenses (2021 - 2025)

Historic Operating Expenses for Tivic Health Systems (TIVC) over the last 5 years, with Q3 2025 value amounting to $2.3 million.

  • Tivic Health Systems' Operating Expenses rose 5850.85% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 686.86%. This contributed to the annual value of $5.7 million for FY2024, which is 3362.63% down from last year.
  • Latest data reveals that Tivic Health Systems reported Operating Expenses of $2.3 million as of Q3 2025, which was up 5850.85% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Tivic Health Systems' Operating Expenses peaked at $3.1 million during Q2 2022, and registered a low of $1.0 million during Q2 2021.
  • Its 5-year average for Operating Expenses is $1.9 million, with a median of $2.0 million in 2025.
  • Its Operating Expenses has fluctuated over the past 5 years, first skyrocketed by 20753.42% in 2022, then plummeted by 4468.65% in 2024.
  • Quarter analysis of 5 years shows Tivic Health Systems' Operating Expenses stood at $2.3 million in 2021, then increased by 0.39% to $2.3 million in 2022, then decreased by 2.17% to $2.2 million in 2023, then tumbled by 44.69% to $1.2 million in 2024, then soared by 87.94% to $2.3 million in 2025.
  • Its Operating Expenses stands at $2.3 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.6 million for Q1 2025.